Safety board clears TxCell to restart Ovasave study that was halted last year
TxCell has been cleared to restart a Phase IIb trial of its candidate Crohn’s disease cell therapy by European regulators.
Archives for May 26, 2016
Inflectra-maker Celltrion to expand biosimilar capacity by 170,000L
Celltrion will invest $275m at its biosimilar production site in Korea to ramp up capacity from 140,000L to 310,000L by 2021.
Biocon granted permission for $158m expansion at Indian biomanufacturing site
Indian drugmaker Biocon has been given the go-ahead to expand a biopharmaceutical manufacturing facility in Bangalore.